OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 101
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 101
Showing 1-25 of 101 citing articles:
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 711-724
Closed Access | Times Cited: 69
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 711-724
Closed Access | Times Cited: 69
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153886-153886
Closed Access | Times Cited: 60
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153886-153886
Closed Access | Times Cited: 60
Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1788-1788
Open Access | Times Cited: 57
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1788-1788
Open Access | Times Cited: 57
Research Progress of Fecal Microbiota Transplantation in Liver Diseases
Yuanyuan Zhao, Gong Chen, Jing Xu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1683-1683
Open Access | Times Cited: 26
Yuanyuan Zhao, Gong Chen, Jing Xu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1683-1683
Open Access | Times Cited: 26
Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma
Sami Fares, Chase J. Wehrle, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1453-1453
Open Access | Times Cited: 13
Sami Fares, Chase J. Wehrle, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1453-1453
Open Access | Times Cited: 13
Poly-L-Lysine–Lactobionic Acid-Capped Selenium Nanoparticles for Liver-Targeted Gene Delivery
Shaigan Naidoo, Aliscia Daniels, Saffiya Habib, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1492-1492
Open Access | Times Cited: 35
Shaigan Naidoo, Aliscia Daniels, Saffiya Habib, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1492-1492
Open Access | Times Cited: 35
Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation
Mauro Giuffrè, Silvia Gazzin, Caterina Zoratti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15564-15564
Open Access | Times Cited: 34
Mauro Giuffrè, Silvia Gazzin, Caterina Zoratti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15564-15564
Open Access | Times Cited: 34
Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma
Vincent Sauzeau, J. Beignet, Gérard Vergoten, et al.
Pharmacological Research (2022) Vol. 179, pp. 106220-106220
Open Access | Times Cited: 30
Vincent Sauzeau, J. Beignet, Gérard Vergoten, et al.
Pharmacological Research (2022) Vol. 179, pp. 106220-106220
Open Access | Times Cited: 30
Radiation Segmentectomy for Hepatocellular Carcinoma
Muhamad Serhal, Farnaz Dadrass, Edward Kim, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 617-628
Open Access | Times Cited: 5
Muhamad Serhal, Farnaz Dadrass, Edward Kim, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 617-628
Open Access | Times Cited: 5
Integrative Quantitative Analysis of Platelet Proteome and Site-Specific Glycoproteome Reveals Diagnostic Potential of Platelet Glycoproteins for Liver Cancer
Xiaofeng Xie, Jian‐Feng Xiang, Huanhuan Zhao, et al.
Analytical Chemistry (2025)
Closed Access
Xiaofeng Xie, Jian‐Feng Xiang, Huanhuan Zhao, et al.
Analytical Chemistry (2025)
Closed Access
Mitochondrial dysfunction-driven AMPK-p53 axis activation underpins the anti-hepatocellular carcinoma effects of sulfane sulfur
Xue Zheng, Yuhua Luo, Rui Huo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Xue Zheng, Yuhua Luo, Rui Huo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity
Rita Andrade, Judith Pérez‐Rojas, Sílvia Silva, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 500-500
Open Access
Rita Andrade, Judith Pérez‐Rojas, Sílvia Silva, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 500-500
Open Access
Diagnostic Values of Magnetic Resonance Imaging and Computed Tomography for Predicting Macrotrabecular-Massive Hepatocellular Carcinoma Subtype: A Meta-analysis
Tian Chai, Yao Tong, Ying Yu, et al.
Academic Radiology (2025)
Closed Access
Tian Chai, Yao Tong, Ying Yu, et al.
Academic Radiology (2025)
Closed Access
Young Adults and Alcohol-Associated Liver Cancer: Incidence and Death from 2000 to 2021
Pojsakorn Danpanichkul, Yanfang Pang, Luis Antonio Díaz, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 609-609
Open Access
Pojsakorn Danpanichkul, Yanfang Pang, Luis Antonio Díaz, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 609-609
Open Access
IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications
Rihan Wu, Hao Yang, Chunlei Liu
Frontiers in Immunology (2025) Vol. 16
Open Access
Rihan Wu, Hao Yang, Chunlei Liu
Frontiers in Immunology (2025) Vol. 16
Open Access
Association between single nucleotide polymorphisms in PNPLA3, TM6SF2 and MBOAT7 genes and markers of cancer aggressiveness in a Sri Lankan NASH-related HCC cohort
Saumya Madushani Samarasinghe, Asanka Sudeshini Hewage, R. C. Siriwardana, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Saumya Madushani Samarasinghe, Asanka Sudeshini Hewage, R. C. Siriwardana, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Latent class analysis‐derived classification for cancer‐specific death stratification of hepatocellular carcinoma
Xiaoyan Jiang, Qianyuan Zhang, Zhong Zheng, et al.
International Journal of Cancer (2025)
Closed Access
Xiaoyan Jiang, Qianyuan Zhang, Zhong Zheng, et al.
International Journal of Cancer (2025)
Closed Access
PBK as a novel biomarker performed excellent diagnostic and prognostic value in HCC associated with immune infiltration and methylation
Beibei Lv, Fen‐Na Zhang, Xinyi Zhang, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access
Beibei Lv, Fen‐Na Zhang, Xinyi Zhang, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access
Surface-Enhanced Raman Spectroscopy for Characterization of Blood Serum Samples of Liver Carcinoma Patients Using 100 kDa Filtration Devices
Saima Afzal, Seher Nawabzadi, Haq Nawaz, et al.
Plasmonics (2025)
Closed Access
Saima Afzal, Seher Nawabzadi, Haq Nawaz, et al.
Plasmonics (2025)
Closed Access
Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
Rainbow Wing Hei Leung, Terence K. Lee
Cancers (2022) Vol. 14, Iss. 21, pp. 5468-5468
Open Access | Times Cited: 20
Rainbow Wing Hei Leung, Terence K. Lee
Cancers (2022) Vol. 14, Iss. 21, pp. 5468-5468
Open Access | Times Cited: 20
BTEAC Catalyzed Ultrasonic-Assisted Synthesis of Bromobenzofuran-Oxadiazoles: Unravelling Anti-HepG-2 Cancer Therapeutic Potential through In Vitro and In Silico Studies
Ali Irfan, Ameer Fawad Zahoor, Azhar Rasul, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3008-3008
Open Access | Times Cited: 12
Ali Irfan, Ameer Fawad Zahoor, Azhar Rasul, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3008-3008
Open Access | Times Cited: 12
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
S. Panneerselvam, Cornelia M. Wilson, Prem Kumar, et al.
Cell Adhesion & Migration (2023) Vol. 17, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
S. Panneerselvam, Cornelia M. Wilson, Prem Kumar, et al.
Cell Adhesion & Migration (2023) Vol. 17, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
New and Old Key Players in Liver Cancer
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17152-17152
Open Access | Times Cited: 11
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17152-17152
Open Access | Times Cited: 11
MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis
Tae‐Hyung Kim, Sungmin Woo, Dong Ho Lee, et al.
European Radiology (2024) Vol. 34, Iss. 10, pp. 6896-6907
Closed Access | Times Cited: 4
Tae‐Hyung Kim, Sungmin Woo, Dong Ho Lee, et al.
European Radiology (2024) Vol. 34, Iss. 10, pp. 6896-6907
Closed Access | Times Cited: 4
Superior cuproptotic efficacy of diethyldithiocarbamate-Cu4O3 nanoparticles over diethyldithiocarbamate-Cu2O nanoparticles in metastatic hepatocellular carcinoma
Marwa M. Abu‐Serie, Assem Barakat, Sherif Ramadan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Marwa M. Abu‐Serie, Assem Barakat, Sherif Ramadan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
